2026 annual financial data
China SXT Pharmaceuticals 2026 Net margin
China SXT Pharmaceuticals 2026 net margin with verified reported values.
Direct answer
Net margin was -578.49%.
Operating income was -7,122,933 USD and net income was -6,205,085 USD.
Operating cash flow was -4,017,456 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,072,632 USD
- Operating income
- -7,122,933 USD
- Net income
- -6,205,085 USD
- Operating cash flow
- -4,017,456 USD
Explore related company data
View all 2026 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all China SXT Pharmaceuticals financial years